Before his pro debut, Anthony Eyanson shares how a childhood diagnosis reshaped his relationship with food—and his sense of ...

Excessive smartphone use is associated with eating disorder symptoms and disordered eating behaviors, including uncontrolled ...

A sharp increase in the number of young people hospitalized with eating disorders immediately after the onset of the COVID-19 ...

Theoretical approaches, treatment preferences, and clinician bias all play a role in the ways we understand eating disorders.

Hilary Duff gets more vulnerable than ever on her new album, luck... or something, but now, she’s opening up about a scarier time in her life. On the March 9 episode of Jay Shetty’s On Purpose podcast ...

Among public health residents, higher risk for eating disorders was independently associated with depressive symptoms, a workload of 40 or more hours per week, and training-related stressors. Medical ...

Please provide your email address to receive an email when new articles are posted on . Eating disorders primarily affect women and typically present early in life. Support should focus on a high ...

CHARLOTTE — Teenagers face mounting pressure to look a certain way or try new things to stay thin due to everything between online influencers and diet culture. Over 30 million people across the U.S.

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...

Content warning: This story discusses eating disorders. Melanie Chisholm is reflecting on a difficult time in her life. Sporty Spice detailed her struggle with an eating disorder towards the end of ...

Mukbang is a global social media trend that originated in South Korea in the early 2010s. Mukbang involves videos of people who eat very large amounts of (often calorie-rich) food in a single sitting.

People say GLP-1 drugs caused them to relapse on long-dormant eating disorders. NY Post/Don Pearsall Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs.